During the past decade, Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "GOG Foundation" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie" are "Breast Cancer" (5 trials), "Ovarian Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie" in a lesser frequency.

Most popular intervention types in "Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials), "Pertuzumab" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie" are 6 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie has several departments that took part in Clinical trials: "Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie" - 21 trials, "Universitätsklinik für Innere Medizin I" - 4 trials, "Medizinische Universität Innsbruck, Universitätsklinik für Herzchirurgie" - 2 trials, "LKH Innsbruck; Universitätsklinik für Dermatologie" - 3 trials, "Lkh innsbruck - univ. Klinikum innsbruck - Tiroler landeskrankenanstalten ges.m.b.h.; Innere Medizin" - 3 trials, "Universitätsklinik Innsbruck, Universitätsklinik für Neurochirurgie" - 2 trials